C-Reactive Protein, Clinical Outcome, and Restenosis Rates After Implantation of Different Drug-Eluting Stents

American Journal of Cardiology

Volumn 97, Issue 9, 2006, Pages 1311-1316

  Gaspardone, Achille ^a   Versaci, Francesco ^b   Tomai, Fabrizio ^c   Citone, Carlo ^a   Proietti, Igino ^a   Gioffrè, Gaetano ^a   Skossyreva, Olga ^a  

^a S EUGENIO HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c EUROPEAN HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL FEATURE; CORONARY STENT; CORRELATION ANALYSIS; DEMOGRAPHY; DRUG ELUTING STENT; DRUG IMPLANTATION; FEMALE; FOLLOW UP; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR; TIME SERIES ANALYSIS;

ANTI-INFLAMMATORY AGENTS; C-REACTIVE PROTEIN; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; DEXAMETHASONE; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 33646020379     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.11.060     Document Type: Article

References (30)

1. Suh W.W., Grill D.E., Rihal C.S., Bell R.M., Holmes Jr. D.R., and Garrat K.N. Unrestricted availability of intracoronary stents is associated with decreased abrupt vascular closure rates and improved early clinical outcomes. Catheter Cardiovasc Interv 55 (2002) 294-302
2. Gaspardone A., Crea F., Versaci F., Tomai F., Pellegrino A., Chiariello L., and Gioffré P.A. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 82 (1998) 515-518
3. Versaci F., Crea F., Gaspardone A., Versaci F., Tomai F., Chiariello L., and Gioffrè P.A. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol 85 (2000) 92-95
4. Hojo Y., Ikeda U., Katsuki T., Mizuno O., Fukazawa H., Kurosaki K., Fujikawa H., and Shimada K. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 84 (2000) 83-87
5. Walter D.H., Fichtlscherer S., Sellwig M., Auch-Schwelk W., Schächinger V., and Zeiher A.M. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 37 (2001) 839-846
6. Fukuda D., Shimada K., Tanaka A., Kawarabayashi T., Yoshiyama M., and Yoshikawa J. Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 43 (2004) 18-23
7. Inoue T., Kato T., Uchida T., Sakuma M., Nakajima A., Shibazaki M., Imoto Y., Sait M., Hashimoto S., Hikichi Y., and Node K. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. J Am Coll Cardiol 46 (2005) 239-245
8. Farb A., Sangiorgi G., Carter A.J., Walley V.M., Edwards W.D., Schwartz R.S., and Virmani R. Pathology of acute and chronic coronary stenting in humans. Circulation 99 (1999) 44-52
9. Farb A., Weber D.K., Kolodgie F.D., Burke A.P., and Virmani R. Morphological predictor of restenosis after coronary stenting in humans. Circulation 105 (2002) 2974-2980
10. Grewe P.H., Deneke T., Machraoui A., Barmeyer J., and Muller K.M. Acute and chronic tissue response to coronary stent implantation. pathologic findings in human specimen. J Am Coll Cardiol 35 (2000) 157-163
11. Inoue T., Uchida T., Yaguchi I., Sakai Y., Takayagi K., and Morooka S. Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis. Circulation 107 (2003) 1757-1763
12. Kornowoski R., Hong M.K., Tio F.O., Bramwell O., Wu H., and Leon M.B. In-stent restenosis. contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 31 (1998) 224-230
13. Fajadet J., Morice M.C., Bode C., Barragan P., Serruys P.W., Wijns W., Constantini C.R., Guermonprez J.L., Eltchaninoff H., Blanchard D., et al. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents. Three year results of the RAVEL Trial. Circulation 111 (2005) 1040-1044
14. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., et al., TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
15. Patti G., Pasceri V., Carminati P., D'Ambrosio A., Carcagni A., and Di Sciascio G. Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol 95 (2005) 502-505
16. Versaci F., Gaspardone A., Tomai F., Ribichini F., Russo P., Proietti I., Ghini A.S., Ferrero V., Chiariello L., Gioffrè P.A., et al. Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS Study). J Am Coll Cardiol 40 (2002) 1935-1942
17. Tunon M.J., Sanchez-Campos S., Gutierrez B., Culebras J.M., and Gonzales-Gallego J. Effects of FK506 and rapamycin on generation of reactive oxygen species, nitric oxide production and nuclear factor kappa B activation in rat hepatocytes. Biochem Pharmacol 66 (2003) 439-445
18. Jackson J.K., Tudan C., Sahl B., Pelech S.L., and Burt H.M. Calcium pyrophosphate dihydrate crystals activate MAP kinase, oxidase activation and degranulation responses of neutrophils by Taxol. Immunology 90 (1997) 502-510
19. Marx S.O., and Marks A.R. Bench to bedside. the development of rapamycin and its application to stent restenosis. Circulation 104 (2001) 852-855
20. Roberts R.L., Nath J., Friedman M.M., and Gallin J.L. Effects of Taxol on human neutrophils. J Immunol 129 (1982) 2134-2141
21. Longhenecker J.P., Kilty L.A., and Johnson L.K. Glucocorticoid inhibition of vascular smooth muscle cell proliferation. influence of homologous extracellular matrix and serum mitogens. J Cell Biol 98 (1984) 534-540
22. MacDonald R.G., Panush R.S., and Pepine C.J. Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 60 suppl (1987) 56B-60B
23. Crea F., Gaspardone A., Tomai F., Shoulders C., De Fazio A., Versaci F., Iamele M., Roncaglioni C., Gioffré M., Maseri A., and Gioffrè P.A. Risk factors in school children associated with a family history of unheralded myocardial infarction or uncomplicated stable angina in male relatives. J Am Coll Cardiol 23 (1994) 1472-1478
24. Hyafner G., Endler T., and Oppitz M. Effects of standardization with the new international reference preparation for proteins in human serum on method comparability and reference values. Clin Lab 41 (1995) 743-748
25. Reiber J.H.C., van Land C.D., and Koning G. Comparison of accuracy and precision of qualitative coronary arterial analysis between cinefilm and digital system. In: Reiber J.H.C., and Serruys P.W. (Eds). Progress in Quantitative Coronary Arteriography (1994), Kluwer Academic Publishers, Dorddrecht, The Netherlands 67-85
26. de la Torre-Hernandez J.M., Sainz-Laso F., Burgos V., Perez T., Figueroa A., Zueco J., and Colman T. Comparison of C-reactive protein levels after coronary stenting with bare metal versus sirolimus-eluting stents. Am J Cardiol 95 (2005) 748-751
27. Suzuki T., Kopia G., Hayashi S., Bailey L.R., Llanos G., Wilensky R., Klugherz B.D., Papandreou G., Narayan P., Leon M.B., et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104 (2001) 1188-1193
28. Romano M.F., Avellino R., Petrella A., Bisogni R., Romano S., and Venuta S. Rapamycin inhibits doxorubicin-induced NF-kB/Rel nuclear activity and enhances apoptosis in melanoma. Eur J Cancer 40 (2004) 2829-2836
29. Hoffman R., Langenberg R., Radke P., Franke A., Blindt R., Ortlepp J., Popma J.J., Weber C., and Hanrath P. Evaluation of a high-dose dexamethasone eluting stent. Am J Cardiol 94 (2004) 193-195
30. Walter D.H., Fichtlscherer S., Britten M.B., Rosin P., Auch-Schwelk W., Schachinger V., and Zeiher A.M. Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation. J Am Coll Cardiol 38 (2001) 2006-2012